Search - tctmd.com

Displaying 21 - 40 of 93

Sort: Relevancy | Date

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

Presentation NY Valves 2024

Hybrid Bailout TAVR to Treat LVOT Obstruction With Late Hemolysis Post Mitral Valve-in-Ring

Presenter: Tarun Chakravarty

June 06, 2024

Presentation NY Valves 2024

Rescue Balloon Valvuloplasty to Resolve LVOT Obstruction During the TMVR With LAMPOON Procedure

Presenter: Ayush Goyal

June 05, 2024

Presentation NY Valves 2024

TMVR in MAC Employing Antegrade Lampoon Technique, With Neo-LVOT 107mm3

Presenter: Praveen Chandra

June 05, 2024

Presentation NY Valves 2024

LVOTO Provocation During Mitral-TEER for Dynamic LVOTO: Poking the Bear

Presenter: Matteo Sturla

June 05, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

L.A. McKeown

March 12, 2024

News Daily News

Aficamten Delivers Positive Results in SEQUOIA-HCM

Todd Neale

December 27, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

Presentation TCT 2023

TCT 498: AltaValve’s Unique Atrial Fixation is Designed to Overcome LVOT Obstruction Risk

Presenter: Vlassis Ninios

October 26, 2023

Presentation TCT 2023

LVOT Obstruction Prevention and Management

Presenter: Robert Lederman

October 24, 2023

Presentation TCT 2023

Adjunctive Techniques to Reduce LVOT Obstruction: ASA, LAMPOON, etc.

Presenter: Jaffar Khan

October 24, 2023

Presentation TVT 2023

Transapical Mechanical Splitting of the AML to Prevent LVOT Obstruction Before TMVR: FIH Experience

Presenter: Danny Dvir

June 10, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

LVOT Obstruction and TMVR – Predictors, Evaluation and Solutions

Presenter: Jaffar Khan

June 09, 2023

Presentation TVT 2023

A challenging case of concomitant severe AS and LVOT obstruction in the setting of HOCM

Presenter: samineh sehatbakhsh

June 08, 2023

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Caitlin E. Cox

May 19, 2023

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

Presentation TCT 2022

Trans-Apical Mechanical Splitting of the Anterior Mitral Leaflet to Prevent LVOT Obstruction Before TMVR: FIH Experience With the SHORTCUT Device

Presenter: Paolo Denti

September 19, 2022

Presentation TCT 2022

CT Imaging for TMVR Planning: Predictors of LVOT Obstruction and Implications for Device Selection

Presenter: Philipp Blanke

September 19, 2022

Advertisement

Pi-Cardia Receives FDA Market Clearance for ShortCut™

Hybrid Bailout TAVR to Treat LVOT Obstruction With Late Hemolysis Post Mitral Valve-in-Ring

Rescue Balloon Valvuloplasty to Resolve LVOT Obstruction During the TMVR With LAMPOON Procedure

TMVR in MAC Employing Antegrade Lampoon Technique, With Neo-LVOT 107mm3

LVOTO Provocation During Mitral-TEER for Dynamic LVOTO: Poking the Bear

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

Aficamten Delivers Positive Results in SEQUOIA-HCM

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

TCT 498: AltaValve’s Unique Atrial Fixation is Designed to Overcome LVOT Obstruction Risk

LVOT Obstruction Prevention and Management

Adjunctive Techniques to Reduce LVOT Obstruction: ASA, LAMPOON, etc.

Transapical Mechanical Splitting of the AML to Prevent LVOT Obstruction Before TMVR: FIH Experience

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

LVOT Obstruction and TMVR – Predictors, Evaluation and Solutions

A challenging case of concomitant severe AS and LVOT obstruction in the setting of HOCM

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

Trans-Apical Mechanical Splitting of the Anterior Mitral Leaflet to Prevent LVOT Obstruction Before TMVR: FIH Experience With the SHORTCUT Device

CT Imaging for TMVR Planning: Predictors of LVOT Obstruction and Implications for Device Selection

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content